Continue Providing Care for Patient Who Participated in the BIA 9-1067-302 Clinical Trial

Trial Profile

Continue Providing Care for Patient Who Participated in the BIA 9-1067-302 Clinical Trial

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Opicapone (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms BIPARK-extension
  • Most Recent Events

    • 23 Jun 2015 Results presented at the 1st Congress of the European Academy of Neurology.
    • 20 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top